Biochemical signs of impaired cobalamin function do not affect hematological parameters in young infants: results

Håvard Bjørke Jenssen1, Ingrid Torsvik, Per Magne Ueland

  • 1Royal College of Surgeons in Ireland, Dublin, Ireland.

Pediatric Research
|June 18, 2013
PubMed

Insights

Cobalamin supplementation did not improve infant blood cell counts, even with biochemical signs of deficiency. Iron status, not cobalamin, was the main factor influencing erythrocyte parameters in infants.

Area of Science:

  • Pediatric Hematology
  • Nutritional Biochemistry
  • Developmental Pediatrics

Background:

  • Cobalamin (vitamin B12) deficiency in infants can cause developmental delay and anemia, though macrocytic anemia is rare and linked to severe deficiency.
  • Iron deficiency is the primary cause of anemia in infants.
  • This study investigated infants with biochemical evidence of impaired cobalamin function.

Purpose of the Study:

  • To assess the impact of cobalamin supplementation on hematological parameters in infants with biochemical signs of impaired cobalamin function.
  • To determine the relationship between cobalamin status and iron status in infant erythropoiesis.

Main Methods:

  • A randomized controlled trial involving 107 infants at 6 weeks of age.
  • Infants received either an intramuscular cobalamin injection (400 μg) or no intervention.
  • Hematological parameters, cobalamin, and folate levels were measured at baseline and 4 months.

Main Results:

  • Cobalamin supplementation improved markers of cobalamin function but did not affect hematological cell counts at 4 months.
  • Signs of iron-restricted erythropoiesis were present at both 6 weeks and 4 months.
  • Male gender and higher weight gain percentage were predictors of low iron status at 4 months.

Conclusions:

  • Cobalamin supplementation does not enhance hematological cell counts in infants with biochemical signs of impaired cobalamin function.
  • Erythrocyte parameter variations in this age group are primarily linked to iron status rather than cobalamin levels.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...